These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1530 related items for PubMed ID: 16285233

  • 21. Gene expression analysis in predicting the effectiveness of insect venom immunotherapy.
    Niedoszytko M, Bruinenberg M, de Monchy J, Wijmenga C, Platteel M, Jassem E, Oude Elberink JN.
    J Allergy Clin Immunol; 2010 May; 125(5):1092-7. PubMed ID: 20334904
    [Abstract] [Full Text] [Related]

  • 22. The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts.
    Bilò MB, Severino M, Cilia M, Pio A, Casino G, Ferrarini E, Campodonico P, Milani M.
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):57-61. PubMed ID: 19663128
    [Abstract] [Full Text] [Related]

  • 23. Diagnosis and treatment of allergy to hymenoptera venoms.
    Hamilton RG.
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):323-9. PubMed ID: 20543672
    [Abstract] [Full Text] [Related]

  • 24. Basophil sensitivity in patients not responding to venom immunotherapy.
    Peternelj A, Silar M, Erzen R, Kosnik M, Korosec P.
    Int Arch Allergy Immunol; 2008 Aug; 146(3):248-54. PubMed ID: 18270492
    [Abstract] [Full Text] [Related]

  • 25. [Allergic reactions to insect bites].
    Urbanek R.
    Ther Umsch; 1989 Sep; 46(9):654-62. PubMed ID: 2678576
    [Abstract] [Full Text] [Related]

  • 26. Safety of hymenoptera venom immunotherapy: a systematic review.
    Incorvaia C, Frati F, Dell'Albani I, Robino A, Cattaneo E, Mauro M, David M, Qualizza R, Pastorello E.
    Expert Opin Pharmacother; 2011 Nov; 12(16):2527-32. PubMed ID: 21883032
    [Abstract] [Full Text] [Related]

  • 27. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
    Bonifazi F, Jutel M, Biló BM, Birnbaum J, Muller U, EAACI Interest Group on Insect Venom Hypersensitivity.
    Allergy; 2005 Dec; 60(12):1459-70. PubMed ID: 16266376
    [Abstract] [Full Text] [Related]

  • 28. Alternating Polistes-Vespula venom immunotherapy: a therapeutic strategy to resolve a diagnostic deficiency.
    Moreno C, Barasona MJ, Serrano P, Justicia JL, Ruz JM, Guerra F.
    J Investig Allergol Clin Immunol; 2011 Dec; 21(1):28-33. PubMed ID: 21370720
    [Abstract] [Full Text] [Related]

  • 29. Adverse reactions to venom immunotherapy.
    Ramirez DA, Londono S, Evans R.
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [Abstract] [Full Text] [Related]

  • 30. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
    Nittner-Marszalska M, Cichocka-Jarosz E, Małaczyńska T, Kraluk B, Rosiek-Biegus M, Kosinska M, Pawłowicz R, Lis G.
    J Investig Allergol Clin Immunol; 2016 Dec; 26(1):40-7. PubMed ID: 27012015
    [Abstract] [Full Text] [Related]

  • 31. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
    Díez Gómez ML, Quirce Gancedo S, Juliá de Páramo B.
    Allergol Immunopathol (Madr); 1995 Dec; 23(6):277-84. PubMed ID: 8579006
    [Abstract] [Full Text] [Related]

  • 32. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.
    Sturm GJ, Heinemann A, Schuster C, Wiednig M, Groselj-Strele A, Sturm EM, Aberer W.
    Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Skin Test Reactivity to Hymenoptera Venom after Venom Immunotherapy Correlates Inversely with the IgG/IgE Ratio.
    Saulite I, Hoetzenecker W, Guenova E, Schmid-Grendelmeier P, Glatz M.
    Int Arch Allergy Immunol; 2017 Aug; 174(3-4):190-199. PubMed ID: 29130986
    [Abstract] [Full Text] [Related]

  • 36. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.
    Ebo DG, Hagendorens MM, Schuerwegh AJ, Beirens LM, Bridts CH, De Clerck LS, Stevens WJ.
    Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386
    [Abstract] [Full Text] [Related]

  • 37. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F, Boquete M, Núñez R, Lombardero M, de la Torre F.
    J Investig Allergol Clin Immunol; 2010 May; 20(6):506-13. PubMed ID: 21243935
    [Abstract] [Full Text] [Related]

  • 38. [Value of specific IgE and IgG4 measurements in the follow-up of a hymenoptera venom immunotherapy treatment: apropos of 82 cases].
    Sonneville A, Loustanau O, Tahar HA, Menelet I.
    Allerg Immunol (Paris); 2000 Jan; 32(1):20-5. PubMed ID: 10723532
    [Abstract] [Full Text] [Related]

  • 39. Immunotherapy with wasp venom is accompanied by wide-ranging immune responses that need further exploration.
    Brasch J, Maidusch T.
    Acta Derm Venereol; 2009 Jan; 89(5):466-9. PubMed ID: 19734970
    [Abstract] [Full Text] [Related]

  • 40. Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy.
    Hemmer W, Focke M, Kolarich D, Wilson IB, Altmann F, Wöhrl S, Götz M, Jarisch R.
    J Allergy Clin Immunol; 2001 Dec; 108(6):1045-52. PubMed ID: 11742287
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 77.